HONG KONG (Reuters) - Patients who fell severely ill with the pandemic H1N1 flu responded well when treated with antibodies harvested from survivors of the disease, a study in Hong Kong has found.
The finding, published in the journal Clinical Infectious Diseases, underlines the importance of using antibodies from recovered patients to treat critically ill people who fail to respond to standard drugs, said lead author Kwok-yung Yuen, a virologist at the University of Hong Kong.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
